Interv Akut Kardiol. 2010;9(1):9-11

Catheter ablation of cavotricuspid isthmus in patients with permanent atrial flutter and dysfunction of left ventricle

David Břečka, Tomáš Minařík
Interní klinika, Fakultní nemocnice, Ostrava

Introduction: Catheter ablation of cavotricuspid isthmus (CTI) has become the first line therapy in patients (pts) with typical atrial flutter.

Methods: Retrospective analysis of patients (n = 61) with permanent typical atrial flutter and systolic dysfunction of left ventricle (left

ventricular ejection fraction (LVEF) ≤ 50 %). All patients underwent catheter ablation of CTI and the effect of ablation on cardiac rhythm

and LVEF after a minimum of 3 months follow-up was analysed with respect to the degree of LV systolic dysfunction and presence of

structural heart disease.

Results: Sinus rhythm (SR) was observed in 51 pts (83.6 %), with 30 only having SR (49.2 %) and 21 having SR with paroxysmal atrial

fibrillation (34.4 %). In 5 pts (8.2 %) we repeated the ablation for recurrence of typical atrial flutter. The mean LVEF after the procedure

increased from 37.8 ± 9.9 % to 43.5 ± 11.4 % (by 15 % in the whole group, p = 0.001), in subgroup with SR, the increase of LVEF was 18.8 %

(p < 0.001). In patients with nonischaemic cardiomyopathy the increase was 19.7 % (p = 0.01) compared to 12.2 % (p = 0.066) in those

with ischaemic heart disease (patients who underwent PCI or CABG).

Conclusions: Catheter ablation of CTI is an effective nonpharmacological therapy of typical atrial flutter, but a relatively large proportion

of patients develop atrial fibrillation (especially its paroxysmal form) during follow-up. The LVEF significantly improved after ablation.

A higher increase was observed in patients with severe LV systolic dysfunction. By contrast, a larger proportion of patients remained

in sinus rhythm in the subgroup with LVEF > 35 %. A more pronounced effect on systolic function of LV was observed in subjects with

nonischaemic cardiomyopathy, compared to patients with ischaemic heart disease.

Keywords: atrial flutter, catheter ablation, cavotricuspid isthmus, left ventricular dysfunction

Published: March 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Břečka D, Minařík T. Catheter ablation of cavotricuspid isthmus in patients with permanent atrial flutter and dysfunction of left ventricle. Interv Akut Kardiol. 2010;9(1):9-11.
Download citation

References

  1. Tai CT, Chen SA. Electrophysiological mechanisms of atrial flutter. J Chin Med Assoc. 2009; 72(2): 60-7. Go to original source... Go to PubMed...
  2. Daoud EG, Morady F. Pathophysiology of atrial flutter. Annu Rev Med. 1998; 49: 77-83. Go to original source... Go to PubMed...
  3. O'Neill MD, Jais P, Jönsson A, Takahashi Y, Sacher F, Hocini M, Sanders P, Rostock T, Rotter M, Clémenty J, Ha?ssaguerre M. An Approach to Catheter Ablation of Cavotricuspid Isthmus Dependent Atrial Flutter. Indian Pacing Electrophysiol J 2006; 6(2): 100-110.
  4. Fischer B, Haissaguerre M, Garrigues S, et al. Radiofrequency catheter ablation of common atrial flutter in 80 patients. J Am Coll Cardiol 1995; 25(6): 1365-1372. Go to original source... Go to PubMed...
  5. Lanzarotti CJ, Olshansky B. Thromboembolism in chronic atrial flutter: is the risk underestimated? Am Coll Cardiol, 1997; 30: 1506-1511. Go to original source... Go to PubMed...
  6. Sawhney NS, Anousheh R, Chen WC, Feld GK. Diagnosis and management of typical atrial flutter. Cardiol Clin. 2009; 27(1). Go to original source... Go to PubMed...
  7. Fiala M. Doporučené postupy pro diagnostiku a léčbu supraventrikulárních arytmií. Cor Vasa 2005; 47(9): 18-39.
  8. Tai CT, Chen SA, Chiang CE, Lee SH, Wen ZC, Huang JL, Chen YJ, Yu WC, Feng AN, Lin YJ, Ding YA, Chang MS. Longterm outcome of radiofrequency catheter ablation for typical atrial flutter: Risk prediction of recurrent arrhythmias. J Cardiovasc Electrophysiol 1998; 9: 115-121. Go to original source... Go to PubMed...
  9. Feld G, Wharton M, Plumb V, Daoud E, Friehling T, Epstein L, EPT-1000 XP Cardiac Ablation System Investigators. Radiofrequency catheter ablation of type 1 atrial flutter using large-tip 8- or 10-mm electrode catheters and a high-output radiofrequency energy generátor. J Am Coll Cardiol, 2004; 43: 1466-1472. Go to original source... Go to PubMed...
  10. Garg A, Feld GK. Atrial Flutter. Curr Treat Options Cardiovasc Med. 2001; 3(4): 277-289. Go to original source... Go to PubMed...
  11. Melo SL, Scanavacca MI, Darrieux FC, Hachul DT, Sosa EA. Ablation of typical atrial flutter: a prospective randomized study of cooled-tip versus 8-mm-tip catheters. Arq Bras Cardiol 2007, 88(3): 273-278. Go to original source... Go to PubMed...
  12. Da Costa A, Jamon Y, Romeyer-Bouchard C, Thevenin J, Messier M, Isaaz K. Catheter selection for ablation of the cavotricuspid isthmus for treatment of typical atrial flutter. J Interv Card Electrophysiol 2006; 17(2): 93-101. Go to original source... Go to PubMed...
  13. Jose A. Luchsinger and Jonathan S. Steinberg. Resolution of cardiomyopathy after ablation of atrial flutter. J Am Coll Cardiol. 1998; 32: 205-210. Go to original source... Go to PubMed...
  14. Michels G, Hoppe UC. Dilated cardiomyopathy in tachycardiac atrial flutter. Dtsch Med Wochenschr 2005; 130(5): 203-205. Go to original source... Go to PubMed...
  15. Bounhoure JP, Boveda S, Albenque JP. Arrhythmia-induced dilated cardiomyopathies. Bull Acad Natl Med. 2006; 190(6): 1225-1235. Go to original source... Go to PubMed...
  16. Umana E, Solares CA, Alpert MA. Tachycardia-induced cardiomyopathy. Am J Med. 2003; 114(1): 51-55. Go to original source... Go to PubMed...
  17. Laurent V, Fauchier L, Pierre B, Grimard C, Babuty D. Incidence and predictive factors of atrial fibrillation after ablation of typical atrial flutter. J Interv Card Electrophysiol. 2009; 24(2): 119-125. Epub 2008. Go to original source... Go to PubMed...
  18. Phillipon F, Plumb VJ, Epstein AE, et al. The risk of atrial fibrillation following radiofrequency catheter ablation of atrial flutter. Circulation 1995; 92: 430-435. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.